Back to Search Start Over

Postconditioning Protection Against Myocardiocyte Anoxia/Reoxygenation Injury From Penehyclidine Hydrochloride.

Authors :
Ren JY
Lin DM
Wang CB
Yang YL
Wang ZQ
Cui BQ
Ma J
Source :
Drug design, development and therapy [Drug Des Devel Ther] 2019 Nov 26; Vol. 13, pp. 3977-3988. Date of Electronic Publication: 2019 Nov 26 (Print Publication: 2019).
Publication Year :
2019

Abstract

Background/aims: To investigate the postconditioning protective effect of penehyclidine hydrochloride (PHC) against anoxia/reoxygenation (A/R) injury in H9c2 cells along with the involved mechanism and timing effect.<br />Methods: We divided H9c2 cells into 7 groups: control group, A/R group and PHC+A/R groups at 0 min, 5 mins, 10 mins, 20 mins, 30 mins, respectively (treated with 0.1 μm/L PHC at 0 min, 5 mins, 10 mins, 20 mins, 30 mins after the reoxygenation procedure began). Cell apoptosis, oxidative stress, intracellular Ca <superscript>2+</superscript> concentration, mitochondrial membrane potential and mitochondrial permeability transition pore (MPTP) opening were explored. Bcl-2, Bax, Cyt C, caspase-3 and caspase-9 levels were measured.<br />Results: A/R significantly increased both cell injury and cell apoptosis. PHC showed postconditioning protective effect by attenuating superoxide production, decreasing Ca <superscript>2+</superscript> overload, restraining MPTP activities, restoring mitochondrial membrane potential, regulating cell apoptosis proteins and modulation of mitochondrial pathway. Earlier administration of PHC offered greater postconditioning protective effect.<br />Conclusion: H9c2 cells were protected by PHC from A/R injury regardless of timing of PHC administration (0 min, 5 mins, 10 mins, 20 mins, 30 mins). However, earlier administration of PHC resulted in better PHC postconditioning protection.<br />Competing Interests: The authors report no conflicts of interest in this work.<br /> (© 2019 Ren et al.)

Details

Language :
English
ISSN :
1177-8881
Volume :
13
Database :
MEDLINE
Journal :
Drug design, development and therapy
Publication Type :
Academic Journal
Accession number :
32063699
Full Text :
https://doi.org/10.2147/DDDT.S224282